| Financial Year |
March 31 2023 |
| Monetary Funds |
5,864,519,223.74 |
| Held-for-trading Financial Assets |
340,000,000.00 |
| Notes Receivable |
290,096,752.87 |
| Accounts Receivable |
2,483,287,515.02 |
| Advances to Suppliers |
167,881,257.66 |
| Other Receivables |
251,474,467.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,518,455,983.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,742,921.68 |
| Total Current Assets |
14,432,640,124.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
568,890,752.94 |
| Investment Properties |
-- |
| Fixed Assetes |
17,609,438,777.56 |
| Under-construction Projects |
4,625,389,843.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,860,252,554.33 |
| R&D expenses |
-- |
| Goodwill |
3,622,704.97 |
| Long-Term Deferred and Prepaid Expenses |
16,245,788.11 |
| Deferred Income Tax Assets |
68,755,406.88 |
| Other Non-Current Assets |
306,334,356.48 |
| Sub-Total of Non-Current Assets |
25,084,980,330.28 |
| Total Assets |
39,517,620,455.25 |
| Short-Term Loans |
1,940,929,029.36 |
| Trading Financial liabilities |
253,075.23 |
| Notes Payable |
570,403,183.55 |
| Accounts Payable |
2,053,767,190.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
185,699,418.46 |
| Taxes Payable |
232,021,331.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
54,838,458.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,308,746,729.17 |
| Other Current Liabilities |
6,294,462.23 |
| Sub-Total of Current Liabilities |
8,431,505,564.40 |
| Long-term Loans |
5,428,721,558.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
258,072,181.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,775,330,418.96 |
| Total Liabilities |
15,206,835,983.36 |
| Paid-In Capital(Or Share Stock) |
3,090,907,356.00 |
| Capital Surplus |
3,613,097,510.81 |
| Surplus Reserve |
1,444,413,940.89 |
| LESS:Treasury Stock |
500,059,711.25 |
| Undistributed Profits |
16,466,884,173.66 |
| Minority Stockholder's Interest |
92,305,798.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,218,478,672.98 |
| Owner's Equity（Stockholder's Equity） |
24,310,784,471.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
39,517,620,455.25 |
